Literature DB >> 16499327

Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus.

Gil Belofsky1, Roberto Carreno, Kim Lewis, Anthony Ball, Gabriele Casadei, George P Tegos.   

Abstract

Two new 2-arylbenzofuran aldehydes (1 and 2) and three known phenolic compounds (3-5) were isolated from organic extracts of Dalea spinosa. These compounds were evaluated for their intrinsic antimicrobial activity and their ability to perform as multidrug-resistance inhibitors by potentiating the activity of known antimicrobials against a variety of pathogenic microorganisms. Compound 1 and its acetate derivative 6 exhibited no direct antimicrobial activity but enhanced the effect of the weak plant antimicrobial berberine when tested against Staphylococcus aureus. Additional potentiation assays with S. aureus overexpression and knockout isogenic efflux mutants for the NorA pump were done in order to assess whether the potentiating effects were associated with inhibition of this known pump mechanism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499327     DOI: 10.1021/np058057s

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  10 in total

1.  Counter-current chromatography based analysis of synergy in an anti-tuberculosis ethnobotanical.

Authors:  Taichi Inui; Yuehong Wang; Shixin Deng; David C Smith; Scott G Franzblau; Guido F Pauli
Journal:  J Chromatogr A       Date:  2007-02-04       Impact factor: 4.759

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

3.  Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis).

Authors:  Hiyas A Junio; Arlene A Sy-Cordero; Keivan A Ettefagh; Johnna T Burns; Kathryn T Micko; Tyler N Graf; Scott J Richter; Robert E Cannon; Nicholas H Oberlies; Nadja B Cech
Journal:  J Nat Prod       Date:  2011-06-10       Impact factor: 4.050

4.  Unbiased evaluation of bioactive secondary metabolites in complex matrices.

Authors:  Taichi Inui; Yuehong Wang; Samuel M Pro; Scott G Franzblau; Guido F Pauli
Journal:  Fitoterapia       Date:  2012-07-02       Impact factor: 2.882

Review 5.  Microbial efflux pump inhibition: tactics and strategies.

Authors:  George P Tegos; Mark Haynes; J Jacob Strouse; Mohiuddin Md T Khan; Cristian G Bologa; Tudor I Oprea; Larry A Sklar
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

6.  Sarothrin from Alkanna orientalis is an antimicrobial agent and efflux pump inhibitor.

Authors:  Jessica R Bame; Tyler N Graf; Hiyas A Junio; R Owen Bussey; Scott A Jarmusch; Tamam El-Elimat; Joseph O Falkinham; Nicholas H Oberlies; Richard A Cech; Nadja B Cech
Journal:  Planta Med       Date:  2013-03-06       Impact factor: 3.352

7.  Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria.

Authors:  Yiannis C Fiamegos; Panagiotis L Kastritis; Vassiliki Exarchou; Haley Han; Alexandre M J J Bonvin; Jacques Vervoort; Kim Lewis; Michael R Hamblin; George P Tegos
Journal:  PLoS One       Date:  2011-04-04       Impact factor: 3.240

8.  Looking to nature for a new concept in antimicrobial treatments: isoflavonoids from Cytisus striatus as antibiotic adjuvants against MRSA.

Authors:  Ana Cristina Abreu; Aline Coqueiro; Andi R Sultan; Nicole Lemmens; Hye Kyong Kim; Robert Verpoorte; Willem J B van Wamel; Manuel Simões; Young Hae Choi
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

Review 9.  Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition.

Authors:  Saikat Dewanjee; Tarun K Dua; Niloy Bhattacharjee; Anup Das; Moumita Gangopadhyay; Ritu Khanra; Swarnalata Joardar; Muhammad Riaz; Vincenzo De Feo; Muhammad Zia-Ul-Haq
Journal:  Molecules       Date:  2017-05-25       Impact factor: 4.411

10.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.